The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 357
RetractedVestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
The natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,079
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Immunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Conti, M., & Beavo, J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,183
(2024) · Climate Change and Law Collection · doi:10.1163/9789004322714_cclc_2023-0172-0836 · Cited by 1,128
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M., & Biswal, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421146 · Cited by 991
Oxidative stress and redox regulation of lung inflammation in COPD
Rahman, I., & Adcock, I. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00053805 · Cited by 944
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
The Pathology of Chronic Obstructive Pulmonary Disease
Hogg, J. C., & Timens, W. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092145 · Cited by 845
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Cosio, M. G., Saetta, M., & Agusti, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804752 · Cited by 815
Vestbo, J., Prescott, E., & Lange, P. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630597 · Cited by 752
Epidemiology and costs of chronic obstructive pulmonary disease
Chapman, K. R., Mannino, D. M., Soriano, J. B., Vermeire, P. A., Buist, A. S., Thun, M. J., Connell, C., Jemal, A., Lee, T. A., Miravitlles, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024505 · Cited by 704
KASAHARA, Y., TUDER, R. M., COOL, C. D., LYNCH, D. A., FLORES, S. C., & VOELKEL, N. F. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2002117 · Cited by 691
How cigarette smoke skews immune responses to promote infection, lung disease and cancer
Stämpfli, M. R., & Anderson, G. P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2530 · Cited by 668
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
From COPD to chronic systemic inflammatory syndrome?
Fabbri, L. M., & Rabe, K. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61383-x · Cited by 635
Pulmonary hypertension in COPD
Chaouat, A., Naeije, R., & Weitzenblum, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00015608 · Cited by 625
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
Antielastin autoimmunity in tobacco smoking–induced emphysema
Lee, S.-H., Goswami, S., Grudo, A., Song, L.-Z., Bandi, V., Goodnight-White, S., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., et al. (2007) · Nature Medicine · doi:10.1038/nm1583 · Cited by 593
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
Histone acetylation and deacetylation: importance in inflammatory lung diseases
Barnes, P. J., Adcock, I. M., & Ito, K. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00117504 · Cited by 564
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings, V. M., Jatakanon, A., Worsdell, Y. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032192 · Cited by 558
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M., & Montminy, M. (2003) · Genes & Development · doi:10.1101/gad.1097103 · Cited by 543
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema
Demedts, I. K., Demoor, T., Bracke, K. R., Joos, G. F., & Brusselle, G. G. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-53 · Cited by 541
Rhyu, D. Y., Yang, Y., Ha, H., Lee, G. T., Song, J. S., Uh, S.-T., & Lee, H. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050425 · Cited by 523
Neutrophil Elastase Contributes to Cigarette Smoke-Induced Emphysema in Mice
Shapiro, S. D., Goldstein, N. M., Houghton, A. M., Kobayashi, D. K., Kelley, D., & Belaaouaj, A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63589-4 · Cited by 520
Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1054 · Cited by 501
Inhibition of osteoblastic bone formation by nuclear factor-κB
Chang, J., Wang, Z., Tang, E., Fan, Z., McCauley, L., Franceschi, R., Guan, K., Krebsbach, P. H., & Wang, C.-Y. (2009) · Nature Medicine · doi:10.1038/nm.1954 · Cited by 481
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
Conti, M., Richter, W., Mehats, C., Livera, G., Park, J.-Y., & Jin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200029200 · Cited by 481
Comorbidities in Chronic Obstructive Pulmonary Disease
Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., & Make, B. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-148et · Cited by 478
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Santos, S., Peinado, V. I., Ramírez, J., Melgosa, T., Roca, J., Rodriguez-Roisin, R., & Barberà, J. A. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00245902 · Cited by 456
Time course of bleomycin‐induced lung fibrosis
Izbicki, G., Segel, M. J., Christensen, T. G., Conner, M. W., & Breuer, R. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00220.x · Cited by 447
Animal models of chronic obstructive pulmonary disease
Wright, J. L., Cosio, M., & Churg, A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90200.2008 · Cited by 447
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Rennard, S. I., Fogarty, C., Kelsen, S., Long, W., Ramsdell, J., Allison, J., Mahler, D., Saadeh, C., Siler, T., Snell, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-995oc · Cited by 439
Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension
Schulz, E., Jansen, T., Wenzel, P., Daiber, A., & Münzel, T. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1989 · Cited by 430
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Houslay, M. D. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.007 · Cited by 430
Sturrock, A., Cahill, B., Norman, K., Huecksteadt, T. P., Hill, K., Sanders, K., Karwande, S. V., Stringham, J. C., Bull, D. A., Gleich, M., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00269.2005 · Cited by 402 · cited 1×
“For example, TGF-b1 up-regulates the expression of NOX4 in human pulmonary artery SMC that is critical in TGF-b1-induced proliferation [213].”
BackgroundRegulation of Mammalian Ciliary Beating
Salathe, M. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.040705.141253 · Cited by 401
Barnes, P. J., Ito, K., & Adcock, I. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15650-x · Cited by 399
Anti-Inflammatory and Immunomodulatory Potential of the Novel PDE4 Inhibitor Roflumilast in Vitro
Hatzelmann, A., & Schudt, C. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29537-9 · Cited by 398
Self-citationBurgin, A. B., Magnusson, O. T., Singh, J., Witte, P., Staker, B. L., Bjornsson, J. M., Thorsteinsdottir, M., Hrafnsdottir, S., Hagen, T., Kiselyov, A. S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1598 · Cited by 397
Kim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36940 · Cited by 397
Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema
Majo, J., Ghezzo, H., & Cosio, M. G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17509460 · Cited by 374
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model
Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 358
Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., Sauleda, J., Miralles, C., Gomez, C., Togores, B., Sala, E., Batle, S., & Busquets, X. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108013 · Cited by 343
Nrf2‐deficient mice are highly susceptible to cigarette smoke‐induced emphysema
Iizuka, T., Ishii, Y., Itoh, K., Kiwamoto, T., Kimura, T., Matsuno, Y., Morishima, Y., Hegab, A. E., Homma, S., Nomura, A., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00905.x · Cited by 336
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Churg, A., Cosio, M., & Wright, J. L. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00390.2007 · Cited by 319
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Cigarette Smoke–induced Emphysema: A Role for the B Cell?
van der Strate, B. W. A., Postma, D. S., Brandsma, C.-A., Melgert, B. N., Luinge, M. A., Geerlings, M., Hylkema, M. N., van den Berg, A., Timens, W., & Kerstjens, H. A. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-594oc · Cited by 311
Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)
O'Donnell, J. M., & Zhang, H.-T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.003 · Cited by 307
Cigarette Smoke Alters Chromatin Remodeling and Induces Proinflammatory Genes in Rat Lungs
Marwick, J. A., Kirkham, P. A., Stevenson, C. S., Danahay, H., Giddings, J., Butler, K., Donaldson, K., MacNee, W., & Rahman, I. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0006oc · Cited by 301
Unique Structural Features That Influence Neutrophil Emigration Into the Lung
Burns, A. R., Smith, C. W., & Walker, D. C. (2003) · Physiological Reviews · doi:10.1152/physrev.00023.2002 · Cited by 297
Underwood, D. C., Osborn, R. R., Bochnowicz, S., Webb, E. F., Rieman, D. J., Lee, J. C., Romanic, A. M., Adams, J. L., Hay, D. W. P., & Griswold, D. E. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.5.l895 · Cited by 297
Grootendorst, D. C., Gauw, S. A., Verhoosel, R. M., Sterk, P. J., Hospers, J. J., Bredenbroker, D., Bethke, T. D., Hiemstra, P. S., & Rabe, K. F. (2007) · Thorax · doi:10.1136/thx.2006.075937 · Cited by 286
Maeno, T., Houghton, A. M., Quintero, P. A., Grumelli, S., Owen, C. A., & Shapiro, S. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8090 · Cited by 282
Song, K. S., Lee, W.-J., Chung, K. C., Koo, J. S., Yang, E. J., Choi, J. Y., & Yoon, J.-H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300096200 · Cited by 281
Cystic Fibrosis Transmembrane Conductance Regulator Function Is Suppressed in Cigarette Smokers
Cantin, A. M., Hanrahan, J. W., Bilodeau, G., Ellis, L., Dupuis, A., Liao, J., Zielenski, J., & Durie, P. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1330oc · Cited by 280
Agusti, À., & Soriano, J. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550801941349 · Cited by 276
Weinberger, M., & Hendeles, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342107 · Cited by 274
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Feghali-Bostwick, C. A., Gadgil, A. S., Otterbein, L. E., Pilewski, J. M., Stoner, M. W., Csizmadia, E., Zhang, Y., Sciurba, F. C., & Duncan, S. R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-014oc · Cited by 269
Molecular pathogenesis of emphysema
Taraseviciene-Stewart, L., & Voelkel, N. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31811 · Cited by 263
Phosphodiesterase Type 5 as a Target for the Treatment of Hypoxia-Induced Pulmonary Hypertension
Sebkhi, A., Strange, J. W., Phillips, S. C., Wharton, J., & Wilkins, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000074226.20466.b1 · Cited by 261
Pulmonary Vascular Involvement in COPD
Peinado, V. I., Pizarro, S., & Barberà, J. A. (2008) · Chest · doi:10.1378/chest.08-0820 · Cited by 260
Wedgwood, S., Dettman, R. W., & Black, S. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.5.l1058 · Cited by 258
Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients
Araya, J., Cambier, S., Markovics, J. A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V. C., Sheppard, D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32526 · Cited by 257
Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats
SCHERMULY, R. T., Kreisselmeier, K. P., Ghofrani, H. A., Yilmaz, H., BUTROUS, G. S., Ermert, L., Ermert, M., Weißmann, N., Rose, F., Guenther, A., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-282oc · Cited by 256
Eickhoff, P., Valipour, A., Kiss, D., Schreder, M., Cekici, L., Geyer, K., Kohansal, R., & Burghuber, O. C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1412oc · Cited by 249
Zhen, G., Park, S. W., Nguyenvu, L. T., Rodriguez, M. W., Barbeau, R., Paquet, A. C., & Erle, D. J. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0180oc · Cited by 248
Souness, J. E., Aldous, D., & Sargent, C. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00185-5 · Cited by 244
Outcomes and markers in the assessment of chronic obstructive pulmonary disease
Jones, P. W., & Agusti, A. G. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00145104 · Cited by 244
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Burgel, P.-R., & Nadel, J. A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00172007 · Cited by 241
Inhibition of PI3Kδ Restores Glucocorticoid Function in Smoking-induced Airway Inflammation in Mice
Marwick, J. A., Caramori, G., Stevenson, C. S., Casolari, P., Jazrawi, E., Barnes, P. J., Ito, K., Adcock, I. M., Kirkham, P. A., & Papi, A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1570oc · Cited by 238
Barr, R. G., Mesia-Vela, S., Austin, J. H. M., Basner, R. C., Keller, B. M., Reeves, A. P., Shimbo, D., & Stevenson, L. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-980oc · Cited by 237
Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?
Teixeira, M. M., Gristwood, R. W., Cooper, N., & Hellewell, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01049-3 · Cited by 237
In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor
Bundschuh, D. S., Eltze, M., Barsig, J., Wollin, L., Hatzelmann, A., & Beume, R. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29538-0 · Cited by 236
Self-citationRahman, I. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:1:167 · Cited by 233
Shao, M. X. G., Nakanaga, T., & Nadel, J. A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00019.2004 · Cited by 233
Elias, J. A., Gustilo, K., Baeder, W., & Freundlich, B. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3812 · Cited by 231
ASSEMBLY OF FUNCTIONAL CFTR CHLORIDE CHANNELS
Riordan, J. R. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.032003.154107 · Cited by 230
Di Stefano, A., Maestrelli, P., Roggeri, A., Turato, G., Calabro, S., Potena, A., Mapp, C. E., Ciaccia, A., Covacev, L., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.3.7509705 · Cited by 228
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shetty, S., Kusminski, C. M., & Scherer, P. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.004 · Cited by 212
New Concepts in the Pathobiology of Chronic Obstructive Pulmonary Disease
Kim, V., Rogers, T. J., & Criner, G. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200802-014et · Cited by 207
Alteration of drug biotransformation and elimination during infection and inflammation
Renton, K. W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00165-6 · Cited by 203
Togo, S., Holz, O., Liu, X., Sugiura, H., Kamio, K., Wang, X., Kawasaki, S., Ahn, Y., Fredriksson, K., Skold, C. M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-929oc · Cited by 202
The Role of Interleukin-1β in Murine Cigarette Smoke–Induced Emphysema and Small Airway Remodeling
Churg, A., Zhou, S., Wang, X., Wang, R., & Wright, J. L. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0038oc · Cited by 201
COPD, a multicomponent disease: implications for management
Agusti, A. G. N. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2004.11.006 · Cited by 196
Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema
Goven, D., Boutten, A., Lecon-Malas, V, Marchal-Somme, J., Amara, N., Crestani, B., Fournier, M., Leseche, G., Soler, P., Boczkowski, J., et al. (2008) · Thorax · doi:10.1136/thx.2007.091181 · Cited by 195
Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke
Martorana, P. A., Beume, R., Lucattelli, M., Wollin, L., & Lungarella, G. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1549oc · Cited by 194
Self-citationThe Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Curtis, J. L., Freeman, C. M., & Hogg, J. C. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-002fm · Cited by 192
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Couillard, A., & Prefaut, C. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00139904 · Cited by 191
An Animal Model of Autoimmune Emphysema
Taraseviciene-Stewart, L., Scerbavicius, R., Choe, K.-H., Moore, M., Sullivan, A., Nicolls, M. R., Fontenot, A. P., Tuder, R. M., & Voelkel, N. F. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1275oc · Cited by 187
Ismail, S., Sturrock, A., Wu, P., Cahill, B., Norman, K., Huecksteadt, T., Sanders, K., Kennedy, T., & Hoidal, J. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90488.2008 · Cited by 177
Bleomycin-Induced Chronic Lung Damage Does Not Resemble Human Idiopathic Pulmonary Fibrosis
BORZONE, G., MORENO, R., URREA, R., MENESES, M., OYARZÚN, M., & LISBOA, C. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2006132 · Cited by 171
Perforin Expression and Cytotoxic Activity of Sputum CD8 + Lymphocytes in Patients With COPD
Chrysofakis, G., Tzanakis, N., Kyriakoy, D., Tsoumakidou, M., Tsiligianni, I., Klimathianaki, M., & Siafakas, N. M. (2004) · Chest · doi:10.1378/chest.125.1.71 · Cited by 167
The Role of Oxidative Stress in Chronic Obstructive Pulmonary Disease
Bowler, R. P., Barnes, P. J., & Crapo, J. D. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200027031 · Cited by 166
CXCR3 and CCR5 Chemokines in Induced Sputum From Patients With COPD
Costa, C., Rufino, R., Traves, S. L., Lapa e Silva, J. R., Barnes, P. J., & Donnelly, L. E. (2008) · Chest · doi:10.1378/chest.07-0393 · Cited by 165
NOX Enzymes and Pulmonary Disease
Griffith, B. D., Pendyala, S., Hecker, L., Lee, P. J., Natarajan, V., & Thannickal, V. J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2599 · Cited by 164
Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants
Bartalesi, B., Cavarra, E., Fineschi, S., Lucattelli, M., Lunghi, B., Martorana, P. A., & Lungarella, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00067204 · Cited by 163
Self-citationAbu-Taha, M., Rius, C., Hermenegildo, C., Noguera, I., Cerda-Nicolas, J.-M., Issekutz, A. C., Jose, P. J., Cortijo, J., Morcillo, E. J., & Sanz, M.-J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803157 · Cited by 162
Self-citationDirect Effects of Caffeine and Theophylline on p110δ and Other Phosphoinositide 3-Kinases
Foukas, L. C., Daniele, N., Ktori, C., Anderson, K. E., Jensen, J., & Shepherd, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202101200 · Cited by 158
Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice
Yao, H., Edirisinghe, I., Rajendrasozhan, S., Yang, S., Caito, S. W., Adenuga, D., & Rahman, I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00439.2007 · Cited by 154
Insulin Resistance and inflammation—A Further Systemic Complication of COPD
Bolton, C. E., Evans, M., Ionescu, A.-S., Edwards, S., Morris, R. H., Dunseath, G. J., Luzio, S. D., Owens, D. R., & Shale, D. J. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701341053 · Cited by 154
Structure‐function Relationships: The Pathophysiology of Airflow Obstruction
Niewoehner, D. E. (2007) · Wiley eBooks · doi:10.1002/9780470755976.ch1 · Cited by 152
Cigarette smoke condensate inhibits transepithelial chloride transport and ciliary beat frequency
Cohen, N. A., Zhang, S., Sharp, D. B., Tamashiro, E., Chen, B., Sorscher, E. J., & Woodworth, B. A. (2009) · The Laryngoscope · doi:10.1002/lary.20223 · Cited by 152
Oligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema
Sullivan, A. K., Simonian, P. L., Falta, M. T., Mitchell, J. D., Cosgrove, G. P., Brown, K. K., Kotzin, B. L., Voelkel, N. F., & Fontenot, A. P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1332oc · Cited by 152
Tobacco Smoke Control of Mucin Production in Lung Cells Requires Oxygen Radicals AP-1 and JNK
Gensch, E. M., Gallup, M., Sucher, A., Li, D., Gebremichael, A., Lemjabbar, H., Mengistab, A., Dasari, V. K., Hotchkiss, J. A., Harkema, J. R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406866200 · Cited by 152
Dunkern, T. R., Feurstein, D., Rossi, G. A., Sabatini, F., & Hatzelmann, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.036 · Cited by 150
Self-citationAlveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice
Summer, R. S., Little, F. F., Ouchi, N., Takemura, Y., Aprahamian, T. R., Dwyer, D. F., Fitzsimmons, K. M., Suki, B., Parameswaran, H., Fine, A., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00397.2007 · Cited by 149
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., & Maltais, F. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972307087205 · Cited by 145
Asthma and COPD : Basic Mechanisms and Clinical Management
Barnes, P. J. (2002) · Cited by 144
Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract
Kreindler, J. L., Jackson, A. D., Kemp, P. A., Bridges, R. J., & Danahay, H. L. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00376.2004 · Cited by 142
Mata, M. (2005) · Thorax · doi:10.1136/thx.2004.025692 · Cited by 137
Acute effects of cigarette smoking on inflammation in healthy intermittent smokers
van der Vaart, H., Postma, D. S., Timens, W., Hylkema, M. N., Willemse, B. W. M., Boezen, H. M., Vonk, J. M., de Reus, D. M., Kauffman, H. F., & ten Hacken, N. H. T. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-22 · Cited by 136
Kokot, A., Metze, D., Mouchet, N., Galibert, M.-D., Schiller, M., Luger, T. A., & Böhm, M. (2009) · Endocrinology · doi:10.1210/en.2008-1315 · Cited by 132
Cigarette Smoke Inhibits Alveolar Repair: A Mechanism for the Development of Emphysema
Rennard, S. I., Togo, S., & Holz, O. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-121sf · Cited by 132
Agents That Elevate cAMP Inhibit Human Neutrophil Apoptosis
Rossi, A. G., Cousin, J. M., Dransfield, I., Lawson, M. F., Chilvers, E. R., & Haslett, C. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2855 · Cited by 131
Modulators of Cigarette Smoke–Induced Pulmonary Emphysema in A/J Mice
March, T. H., Wilder, J. A., Esparza, D. C., Cossey, P. Y., Blair, L. F., Herrera, L. K., McDonald, J. D., Campen, M. J., Mauderly, J. L., & Seagrave, J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl016 · Cited by 128
Timmer, W., Leclerc, V., Birraux, G., Neuhäuser, M., Hatzelmann, A., Bethke, T. D., & Wurst, W. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011328 · Cited by 126
Self-citationProstaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
Huang, S. K., Wettlaufer, S. H., Chung, J., & Peters-Golden, M. L. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0080oc · Cited by 126
Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs
Burnouf, C., & Pruniaux, M. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394665 · Cited by 124
Namkoong, S., Kim, C., Cho, Y.-L., Kim, J.-H., Lee, H., Ha, K., Choe, J., Kim, P.-H., Won, M., Kwon, Y.-G., et al. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.038 · Cited by 123
Riise, G. C., Larsson, S., Lofdahl, C., & Andersson, B. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07091673 · Cited by 116
Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin‐induced lung injury
Cortijo, J., Iranzo, A., Milara, X., Mata, M., Cerdá‐Nicolás, M., Ruiz‐Saurí, A., Tenor, H., Hatzelmann, A., & Morcillo, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00041.x · Cited by 114
Self-citationSanz, M., Cortijo, J., & Morcillo, E. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.12.001 · Cited by 114
Self-citationMcAnulty, R. J., Hernández-Rodríguez, N. A., Mutsaers, S. E., Coker, R. K., & Laurent, G. J. (1997) · Biochemical Journal · doi:10.1042/bj3210639 · Cited by 114
Grinnell, F., & Ho, C.-H. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5445 · Cited by 113
Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease
Summer, R. S., Fiack, C. A., Ikeda, Y., Sato, K., Dwyer, D. F., Ouchi, N., Fine, A., Farber, H. W., & Walsh, K. X. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90599.2008 · Cited by 112
Is Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Taraseviciene-Stewart, L., Douglas, I. S., Nana-Sinkam, P. S., Lee, J. D., Tuder, R. M., Nicolls, M. R., & Voelkel, N. F. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-105sf · Cited by 109
Freeman, C. M., Curtis, J. L., & Chensue, S. W. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061177 · Cited by 108
Are phosphodiesterase 4 inhibitors just more theophylline?
Boswell‐Smith, V., Cazzola, M., & Page, C. P. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.045 · Cited by 107
Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
Dastidar, S. G., Rajagopal, D., & Ray, A. (2007) · PubMed · Cited by 105
Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD
Sapey, E., Ahmad, A., Bayley, D., Newbold, P., Snell, N. J. C., Rugman, P., & Stockley, R. A. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9286-8 · Cited by 105
Rehan, V. K., Asotra, K., & Torday, J. S. (2009) · Lung · doi:10.1007/s00408-009-9158-2 · Cited by 104
Attenuation by oralN-acetylcysteine of bleomycin-induced lung injury in rats
Cortijo, J., Cerdá‐Nicolás, M., Serrano‐Mollar, A., Bioque, G., Estrela, J. M., Santangelo, F., Esteras, A., Llombart‐Bosch, A., & Morcillo, E. J. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00049701 · Cited by 104
Self-citationNew insights into the regulation of inflammation by adenosine
Linden, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29125 · Cited by 103
Claveau, D., Chen, S. L., O’Keefe, S. J., Zaller, D. M., Styhler, A., Liu, S., Huang, Z., Nicholson, D. W., & Mancini, J. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064691 · Cited by 102
The Efficacy and Safety of Cilomilast in COPD
Rennard, S. I., Knobil, K., Rabe, K. F., Morris, A. N., Schachter, N., Locantore, N., Canonica, G. W., Zhu, Y.-J., & Barnhart, F. (2008) · Drugs · doi:10.2165/0003495-200868002-00002 · Cited by 102
Gray, T. E., Nettesheim, P., Loftin, C. D., Koo, J.-S., Bonner, J. C., Peddada, S. D., & Langenbach, R. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.337 · Cited by 102
Quément, C. L., Guénon, I., Gillon, J., Valença, S. S., Cayron-Elizondo, V., Lagente, V., & Boichot, E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.180 · Cited by 101
The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro
Jones, N. A., Boswell‐Smith, V., Lever, R., & Page, C. P. (2004) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2004.10.001 · Cited by 100
Motz, G. T., Eppert, B. L., Sun, G., Wesselkamper, S. C., Linke, M. J., Deka, R., & Borchers, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8036 · Cited by 98
Chronic Obstructive Lung Disease
(2005) · Springer eBooks · doi:10.1007/3-540-29623-9_5742 · Cited by 98
PDE4 inhibitors in COPD—a more selective approach to treatment
Vignola, A. M. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2003.12.012 · Cited by 96
Shigemura, N., Sawa, Y., Mizuno, S., Ono, M., Ohta, M., Nakamura, T., Kaneda, Y., & Matsuda, H. (2005) · Circulation · doi:10.1161/01.cir.0000158433.89103.85 · Cited by 94
PDE4 Inhibitors Attenuate Fibroblast Chemotaxis and Contraction of Native Collagen Gels
Kohyama, T., Liu, X., Wen, F., Zhu, Y. K., Wang, H., Kim, H. J., Takizawa, H., Cieslinski, L. B., Barnette, M. S., & Rennard, S. I. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.6.4743 · Cited by 92
Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes
Ukena, D., Schudt, C., & Sybrecht, G. W. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90168-v · Cited by 92
Self-citationOralN‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats
Mata, M., Ruíz, A., Cerdá, M., Martínez‐Losa, M., Cortijo, J., Santangelo, F., Serrano‐Mollar, A., Llombart‐Bosch, A., & Morcillo, E. J. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00018003 · Cited by 92
Self-citationPlasma leptin and adiponectin in COPD exacerbations: Associations with inflammatory biomarkers
Krommidas, G., Κostikas, Κ., Papatheodorou, G., Koutsokera, A., Gourgoulianis, K. I., Roussos, C., Koulouris, N. G., & Loukides, S. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.08.012 · Cited by 90
Muzaffar, S., Shukla, N., Lobo, C., Angelini, G. D., & Jeremy, J. Y. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705626 · Cited by 88
Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities
Barnes, P. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-069th · Cited by 88
Choy, J. C., Cruz, R. P., Kerjner, A., Geisbrecht, J., Sawchuk, T., Fraser, S. A., Hudig, D., Bleackley, R. C., Jirik, F. R., McManus, B. M., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00710.x · Cited by 85
Waddleton, D. M., Wu, W.-Z., Feng, Y., Thompson, C., Wu, M., Zhou, Y.-P., Howard, A., Thornberry, N., Li, J., & Mancini, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.025 · Cited by 82
Immunological/physiological relationships in asthma: potential regulation by lung macrophages
Poulter, L. W., Janossy, G., Power, C. K., Sreenan, S., & Burke, C. M. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90004-3 · Cited by 81
Zhang, R., Maratos–Flier, E., & Flier, J. S. (2009) · Endocrinology · doi:10.1210/en.2009-0108 · Cited by 80
Sanz, M., Cortijo, J., Abu-Taha, M. I., Cerdá‐Nicolás, M., Schatton, E., Burgbacher, B., Klar, J., Tenor, H., Schudt, C., Issekutz, A. C., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707428 · Cited by 75
Self-citationSousa, L. P., Carmo, A. A. F., Rezende, B. M., Lopes, F., Silva, D. M., Alessandri, A. L., Bonjardim, C. A., Rossi, A. G., Teixeira, M. M., & Pinho, V. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.030 · Cited by 74
Zhang, A., Wang, M.-H., Dong, Z., & Yang, T. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00480.2005 · Cited by 74
Pittman, N. S., Shue, G., LeLeiko, N. S., & Walsh, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28848 · Cited by 72
Nozik‐Grayck, E., & Stenmark, K. R. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-75434-5_8 · Cited by 70
PDE4 inhibitors roflumilast and rolipram augment PGE 2 inhibition of TGF-β1-stimulated fibroblasts
Togo, S., Liu, X., Wang, X., Sugiura, H., Kamio, K., Kawasaki, S., Kobayashi, T., Ertl, R. F., Ahn, Y., Holz, O., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00508.2007 · Cited by 70
Hohlfeld, J. M., Schoenfeld, K., Lavae-Mokhtari, M., Schaumann, F., Mueller, M., Bredenbroeker, D., Krug, N., & Hermann, R. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.02.002 · Cited by 68
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD
Tkáčová, R., Kluchová, Z., Joppa, P., Petrášová, D., & Molčányiová, A. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.03.005 · Cited by 66
Smad3 mediates TGF-β1-induced collagen gel contraction by human lung fibroblasts
Kobayashi, T., Liu, X., Wen, F., Kohyama, T., Shen, L., Wang, X., Hashimoto, M., Mao, L., Togo, S., Kawasaki, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.209 · Cited by 64
Activation of Neutrophils within Pulmonary Microvessels of Rabbits Exposed to Cigarette Smoke
Klut, M. E., Doerschuk, C. M., van Eeden, S. F., Burns, A. R., & Hogg, J. C. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/9.1.82 · Cited by 64
The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release
Ong, W., Gribble, F. M., Reimann, F. M., Lynch, M., Houslay, M. D., Baillie, G. S., Furman, B. L., & Pyne, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00194.x · Cited by 63
Bleomycin-Mediated Pulmonary Toxicity: Evidence for a p53-Mediated Response
Mishra, A., Doyle, N. A., & Martin, W. J. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.5.3851 · Cited by 60
Liu, S., Veilleux, A., Zhang, L., Young, A. J., Kwok, E., Laliberté, F., Chung, C., Tota, M. R., Dubé, D., Friesen, R. W., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.083519 · Cited by 59
Mayeenuddin, L. H., & Garrison, J. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506035200 · Cited by 58
Growcott, E. J., Spink, K. G., Ren, X., Afzal, S., Banner, K. H., & Wharton, J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-9 · Cited by 55
A2B Adenosine Receptors Regulate the Mucus Clearance Component of the Lung's Innate Defense System
Rollins, B., Burn, M., Coakley, R. D., Chambers, L. A., Hirsh, A. J., Clunes, M. T., Lethem, M. I., Donaldson, S. H., & Tarran, R. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0450oc · Cited by 55
Guérard, P., Rakotoniaina, Z., Goirand, F., Rochette, L., Dumas, M., Lirussi, F., & Bardou, M. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0082-1 · Cited by 54
Kroegel, C., & Foerster, M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.109 · Cited by 54
Toward, T. J., & Broadley, K. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033951 · Cited by 52
Cavarra, E., Carraro, F., Fineschi, S., Naldini, A., Bartalesi, B., Pucci, A., & Lungarella, G. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00170.2004 · Cited by 52
Self-citationMcCahill, A., Huston, E., Li, X., & Houslay, M. D. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_6 · Cited by 49
Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy
Hinkle, R. T., Dolan, E. T., Cody, D. B., Bauer, M. B., & Isfort, R. J. (2005) · Muscle & Nerve · doi:10.1002/mus.20416 · Cited by 49
Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease
Soto, F. J., & Hanania, N. A. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.mcp.0000151715.58124.9e · Cited by 47
Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases
Lagente, V., Martin‐Chouly, C., Boichot, E., Martins, M. A., & Silva, P. M. (2005) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762005000900023 · Cited by 47
PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast.
Boswell‐Smith, V., & Spina, D. (2007) · PubMed · Cited by 45
Attenuation of acute lung inflammation induced by cigarette smoke in CXCR3 knockout mice
Nie, L., Xiang, R., Zhou, W., Lu, B., Cheng, D., & Gao, J. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-82 · Cited by 45
Izikki, M., Raffestin, B., Klar, J., Hatzelmann, A., Marx, D., Tenor, H., Zadigue, P., Adnot, S., & Eddahibi, S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.148742 · Cited by 44
Self-citationWang, Y., Lam, C. S., Wu, F., Wang, W., Duan, Y., & Huang, P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00627.2004 · Cited by 41
Yoshihiro, W., Horita, T., Ken-ichi, M., Keiichi, O., & Kasugai, S. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.79.477 · Cited by 41
Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: anin vitrostudy
Peinado, V. I., Santos, S., Ramírez, J., Roca, J., Rodríguez-Roisin, R., & Barberà, J. A. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00282002 · Cited by 40
4D or not 4D – the emetogenic basis of PDE4 inhibitors uncovered?
Giembycz, M. A. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02089-8 · Cited by 38
Effect of cigarette smoke on fibroblast-mediated gel contraction is dependent on cell density
Wang, H., Liu, X., Umino, T., Kohyama, T., Zhu, Y. K., Wen, F., Spurzem, J. R., Romberger, D. J., Kim, H. J., & Rennard, S. I. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00042.2002 · Cited by 37
Sabatini, F., Petecchia, L., Boero, S., Silvestri, M., Klar, J., Tenor, H., Beume, R., Hatzelmann, A., & Rossi, G. A. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.02.004 · Cited by 36
Self-citationSköld, C. M., Liu, X., Zhu, Y. K., Umino, T., Takigawa, K., Ohkuni, Y., Ertl, R. F., Spurzem, J. R., Romberger, D. J., Brattsand, R., et al. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99269.x · Cited by 36
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Glucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
New anti-inflammatory targets for chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4025 · Cited by 392
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Metadata
- Authors
- Hatzelmann, A., Morcillo, E. J., Lungarella, G., Adnot, S., Sanjar, S., Beume, R., Schudt, C., & Tenor, H.
- Venue
- Pulmonary Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 23
- Issue
- 4
- Pages
- 235-256
- ISSN
- 1094-5539 (ISSN-L)
- OpenAlex
- W1971574036
- Cited by
- 320
- References
- 221
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.